UTHR United Therapeutics Corporation
United Therapeutics Corporation (UTHR) is expected to report earnings on February 3, 2027, before the market open. The consensus earnings estimate is $6.36 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.2% since its last earnings release on November 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About United Therapeutics Corporation
United Therapeutics Corp is a biotechnology company. The Company is engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.
Sector
Healthcare
Industry
Drug Manufacturers/Other
Held By 3 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.